(Q48026853)

7 February 2018

title

Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine (English)

1 reference

7 February 2018

1 reference

Yoo YC

1

1 reference

7 February 2018

Yoshimatsu K

2

1 reference

7 February 2018

Koike Y

3

1 reference

7 February 2018

Hatsuse R

4

1 reference

7 February 2018

Yamanishi K

5

1 reference

7 February 2018

Tanishita O

6

1 reference

7 February 2018

Arikawa J

7

1 reference

7 February 2018

Azuma I

8

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

7 February 2018

published in

Vaccine

1 reference

7 February 2018

volume

16

1 reference

7 February 2018

issue

2-3

1 reference

7 February 2018

page(s)

216-224

1 reference

7 February 2018

Mode of action of non-histone proteins in the stimulation of transcription from DNA

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Adjuvant activity of monomeric bacterial cell wall peptidoglycans.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Synthetic immunoadjuvants: application to non-specific host stimulation and potentiation of vaccine immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Effect of N alpha-acetylmuramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl- L-lysine on resistance to herpes simplex virus type-1 infection in cyclophosphamide-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Suppression of Sendai virus growth by treatment with N alpha-acetylmuramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl-L-lysine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Effect of MDP-Lys(L18), a derivative of MDP, on enhancing host resistance against Hantaan virus infection in newborn mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

B30-MDP, a synthetic muramyl dipeptide derivative for tumour vaccination to enhance antitumour immunity and antimetastatic effect in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

A Current Appraisal of Hemorrhagic Fevers in the U.S.S.R. *

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Characterization of Hantaan virions, the prototype virus of hemorrhagic fever with renal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Isolation of the Etiologic Agent of Korean Hemorrhagic Fever

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Adjuvants--a balance between toxicity and adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

1 reference

7 January 2021

Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Isolation of virus causing hemorrhagic fever with renal syndrome (HFRS) through a cell culture system.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Comparison of virulence between Seoul virus strain SR-11 and Hantaan virus strain 76-118 of hantaviruses in newborn mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Development of inactivated vaccine against virus causing haemorrhagic fever with renal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Adjuvants: current status, clinical perspectives and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Improvement of hepatitis B vaccine by the use of a new adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Cytokine regulation of T-cell function: potential for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Role of T lymphocyte subsets in protection and recovery from Hantaan virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

Pathogenesis of Hantaan virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900188-6

7 January 2021

10.1016/S0264-410X(97)00188-6

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018